Key Takeaways
May 2, 2026 · 2 min read · By Rishabh Bhardwaj
·
AI-assisted, human-reviewed · Our editorial standards
A federal appeals court has ruled that mifepristone, the most commonly used abortion medication in the United States, cannot be sent to patients by mail. The decision strikes at one of the main ways abortion access has been preserved since the Supreme Court overturned Roe v. Wade in 2022.
After the Supreme Court removed the federal right to abortion in 2022, many states moved quickly to ban or restrict the procedure. Telehealth providers stepped in to fill the gap: doctors in states where abortion remains legal prescribe mifepristone remotely, and the pills are mailed directly to patients in restricted states. This route became a critical lifeline for millions of people who could not travel to a clinic.
Mifepristone is approved by the FDA and is used in the majority of abortions in the US. It works by blocking a hormone needed for pregnancy to continue, and is typically used in combination with a second drug, misoprostol. The two-drug regimen is considered safe and effective by major medical bodies.
The appeals court ruling means mail delivery of mifepristone is no longer permitted under its jurisdiction. Patients in states with abortion restrictions who relied on telehealth prescriptions and mail-order delivery will lose that option if the ruling stands or is upheld further. It also raises the compliance burden for telehealth providers who have built services around this model.
The ruling is likely to face further legal challenges. It could be appealed to the Supreme Court, which has already weighed in on mifepristone access in a separate case. That earlier case, decided in 2024, kept the drug available nationally on procedural grounds without resolving the underlying access questions, meaning the legal fight over mail delivery remains open.
For now, providers and patients in affected states face immediate uncertainty. Those tracking this case should watch whether the ruling is stayed pending appeal, which states fall under the court's jurisdiction, and whether the Supreme Court agrees to hear a follow-up challenge.
India's Expenditure Finance Committee has cleared a Rs 1.25 lakh crore outlay for India Semiconductor Mission 2.0, up 64 percent from ISM 1.0's Rs 76,000 crore. The proposal now goes to the Cabinet, as two chip plants begin commercial output and a third, CG Semi, is set to open July 4, 2026.
The Supreme Court blocked Trump from firing Federal Reserve board member Lisa Cook, preserving the Fed's independence from presidential removal power. A separate ruling the same day gave Trump broader authority to dismiss leaders of other independent federal agencies.
The US Supreme Court has blocked President Trump's attempt to fire Federal Reserve governor Lisa Cook, who faced unproven mortgage fraud allegations. The ruling preserves Fed independence for now and keeps a politically charged removal case alive in the courts.
The US Supreme Court, splitting along ideological lines, has allowed the Trump administration to end Temporary Protected Status for Haitian and Syrian immigrants.